Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Acquires Swedish PCR Dx Kit Shop Sangtec for $27M in Cash

NEW YORK (GenomeWeb News) — Cepheid today said it has acquired PCR diagnostics company Sangtec Molecular Diagnostics from Altana Pharma for around $27 million in cash.   
Cepheid CEO John Bishop said the acquisition gives the company a “relatively complete line of products for managing infections of immunocompromised patients.”  
 
Bishop said the firm will also provide Cepheid with an established reagent-manufacturing base in Europe.
 
Cepheid said it will integrate Sangtec’s PCR diagnostic kits into its European and US in vitro product line, which will now offer assays for cytomegalovirus, Epstein-Barr virus, herpes simplex virus 1 and 2, hepatitis B virus, Varicella zoster virus, BK virus and Aspergillus.
 
Sangtec brings with it an R&D team with real-time PCR experience and an experienced manufacturing team as well, Bishop added.
 
Sangtec generated around $8 million in revenue last year and has 59 employees, Cepheid said.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.